Brief: Sun Pharma Receives Sahpra Approval To Manufacture And Market Generic Semaglutide In South Africa
BRIEF-Sun Pharma Receives Sahpra Approval To Manufacture And Market Generic Semaglutide In South Africa July 15 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS:
SUN PHARMA - PHARMA RECEIVES SAHPRA APPROVAL TO MANUFACTURE AND MARKET GENERIC SEMAGLUTIDE IN SOUTH AFRICA
Source text: ID:nBSE9KDTCd
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses